Back to Search Start Over

Ocular involvement in children with localised scleroderma: a multi-centre study

Authors :
Maria Elisabetta Zannin
Giorgia Martini
Balu H. Athreya
Ricardo Russo
Gloria Higgins
Fabio Vittadello
Maria Giannina Alpigiani
Mauro Paradisi
Patricia Woo
Francesco Zulian
Juvenile Scleroderma Working
ALESSIO, MARIA
Maria Elisabetta, Zannin
Giorgia, Martini
Balu H., Athreya
Ricardo, Russo
Gloria, Higgin
Fabio, Vittadello
Maria Giannina, Alpigiani
Alessio, Maria
Mauro, Paradisi
Patricia, Woo
Francesco, Zulian
Juvenile Scleroderma, Working
Publication Year :
2007

Abstract

Background: Most of the available documentation in the literature on ocular involvement in localised scleroderma (LS) are descriptions of single cases in adult patients. This article reports the frequency and specific features of ocular involvement in a large cohort of children with juvenile LS (JLS). Methods: Data from a large, multi-centre, multinational study of children with LS were used to collect and analyse specific information on ocular involvement. Results: 24 out of 750 patients (3.2%) revealed a significant ocular involvement. 16 were female and 8 male. 16 patients (66.7%) had scleroderma “en coup de sabre” (ECDS) of the face, 5 (20.8%) had the linear subtype, 2 (8.3%) had generalised morphea (GM) and one (4.2%) had plaque morphea (PM). Of the 24 patients with eye involvement, 10 patients (41.7%) reported adnexa (eyelids and eyelashes) abnormalities, 7 (29.2%) anterior segment inflammation (5 anterior uveitis, 2 episcleritis) and 3 central nervous system-related abnormalities. 4 patients presented single findings such as paralytic strabismus (1), pseudopapilloedema (1) and refractive errors (2). Other extracutaneous manifestations were detected in a significantly higher number of patients with ocular involvement and were mostly neurological. Conclusion: Ocular abnormalities are not unusual in patients with JLS, especially in the ECDS subtype. They are frequently associated with other internal organ involvement, particularly the central nervous system (CNS). Careful ophthalmic monitoring is recommended for every patient with JLS, but is mandatory in those with skin lesions on the face and/or concomitant CNS involvement.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....988fe0ee18bc3593e89941500ee361bc